Enhancement of the Physical and Chemical Stability of Amorphous Drug-Polymer Mixtures via Cryogenic Comilling

被引:15
作者
Romanini, Michela [1 ,2 ]
Lorente, Marta [1 ,2 ]
Schamme, Benjamin [3 ]
Delbreilh, Laurent [4 ]
Dupray, Valerie [3 ]
Coquerel, Gerard [3 ]
Lluis Tamarit, Josep [1 ,2 ]
Macovez, Roberto [1 ,2 ]
机构
[1] Univ Politecn Cataluna, Dept Fis, Grp Caracteritzacio Mat, EEBE, Campus Diagonal Besos,Ave Eduard Maristany 10-14, E-08019 Barcelona, Spain
[2] Univ Politecn Cataluna, Barcelona Res Ctr Multiscale Sci & Engn, EEBE, Campus Diagonal Besos,Ave Eduard Maristany 10-14, E-08019 Barcelona, Spain
[3] Univ Rouen Normandie, Lab Sci & Methodes Separat SMS EA3233, F-76821 Mont St Aignan, France
[4] Normandie Univ, UNIROUEN, Grp Phys Mat, CNRS,INSA Rouen, F-76000 Rouen, France
关键词
ACTIVE PHARMACEUTICAL INGREDIENT; CRYSTALLIZATION KINETICS; MOLECULAR MOBILITY; RELAXATION DYNAMICS; WATER; SOLUBILITY; BEHAVIOR; DISPERSIONS; ABSORPTION; CONDUCTION;
D O I
10.1021/acs.macromol.8b01271
中图分类号
O63 [高分子化学(高聚物)];
学科分类号
070305 ; 080501 ; 081704 ;
摘要
Amorphous dispersions of the Biclotymol antiseptic are obtained in polyvinylpyrrolidone (PVP), for different drug loadings, by comilling at temperatures below the glass transition of both components. Characterization of the dispersions by scanning differential calorimetry and temperature-dependent broadband dielectric spectroscopy shows them to be homogeneous amorphous molecular mixtures. A single glass transition with pronounced enthalpy recovery peak is observed, indicative of the formation of a homogeneous glass state characterized by substantial aging. The polymer has a considerable antiplasticizing effect on the drug, increasing its glass transition temperature (T-g) to well above room temperature. The T-g of the mixture increases linearly with the macromolecular mass fraction. Three (macro)molecular relaxations are identified in the isothermal dielectric spectra of the mixtures. The slowest process corresponds to the cooperative (alpha relaxation) dynamics of the polymer chains and drug molecules simultaneously, and its relaxation time becomes longer the higher the polymer content. The fastest one is an intramolecular relaxation mode of Biclotymol and is virtually unaffected by the presence of the polymer. Finally, the intermediate relaxation, which is also observed in pure PVP, is assigned to the motion of the polymer side groups. Its activation barrier increases with increasing drug content, indicative of a direct interaction of the drug with the pyrrolidone moieties, likely via hydrogen bonding to the carbonyl oxygen. Contrary to pure PVP, the mixtures are not hygroscopic. Mechanical amorphization by cryomilling thus yields glassy molecular mixtures at arbitrary drug concentration, with enhanced physical stability against crystallization and enhanced chemical stability against hydrolysis reactions.
引用
收藏
页码:9382 / 9392
页数:11
相关论文
共 50 条
  • [41] Drug-polymer miscibility, interactions, and precipitation inhibition studies for the development of amorphous solid dispersions for the poorly soluble anticancer drug flutamide
    Trivino, Anne
    Gumireddy, Ashwini
    Meng, Fan
    Prasad, Dev
    Chauhan, Harsh
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2019, 45 (08) : 1277 - 1291
  • [42] Investigation of drug-polymer miscibility and design of ternary solid dispersions for oral bioavailability enhancement by Hot Melt Extrusion
    Pisay, Muralidhar
    Navti, Prerana D.
    Rao, Vinay
    Koteshwara, Kunnatur Balasundara
    Mutalik, Srinivas
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2023, 90
  • [43] Implications of Drug-Polymer Interactions on Time-Temperature-Transformation: A Tool to Assess the Crystallization Propensity in Amorphous Solid Dispersions
    Lalge, Rahul
    Kumar, N. S. Krishna
    Suryanarayanan, Raj
    MOLECULAR PHARMACEUTICS, 2023, : 1806 - 1817
  • [44] Effect of Variability of Physical Properties of Povidone K30 on Crystallization and Drug-Polymer Miscibility of Celecoxib-Povidone K30 Amorphous Solid Dispersions
    Phadke, Chaitali
    Sharma, Jagadish
    Sharma, Kunnal
    Bansal, Arvind K.
    MOLECULAR PHARMACEUTICS, 2019, 16 (10) : 4139 - 4148
  • [45] Physical stability of API/polymer-blend amorphous solid dispersions
    Lehmkemper, Kristin
    Kyeremateng, Samuel O.
    Bartels, Mareike
    Degenhardt, Matthias
    Sadowski, Gabriele
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2018, 124 : 147 - 157
  • [46] Physical stability of L-ascorbic acid amorphous solid dispersions in different polymers: A study of polymer crystallization inhibitor properties
    Christina, Belinda
    Taylor, Lynne S.
    Mauer, Lisa J.
    FOOD RESEARCH INTERNATIONAL, 2015, 76 : 867 - 877
  • [47] Co-amorphous Drug Delivery Systems: a Review of Physical Stability, In Vitro and In Vivo Performance
    Shi, Qin
    Wang, Yanan
    Moinuddin, Sakib M.
    Feng, Xiaodong
    Ahsan, Fakhrul
    AAPS PHARMSCITECH, 2022, 23 (07)
  • [48] Indomethacin co-amorphous drug-drug systems with improved solubility, supersaturation, dissolution rate and physical stability
    Fael, Hanan
    Demirel, A. Levent
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2021, 600
  • [49] Stability of co-Amorphous Solid Dispersions: Physical and Chemical Aspects
    Aher, Abhijeet A.
    Shaikh, Karimunnisa S.
    Chaudhari, Praveen D.
    JOURNAL OF STRUCTURAL CHEMISTRY, 2023, 64 (04) : 686 - 738
  • [50] Determination of drug-polymer solubility from supersaturated spray-dried amorphous solid dispersions: A case study with Efavirenz and Soluplus®
    Costa, B. L. A.
    Sauceau, M.
    Del Confetto, S.
    Sescousse, R.
    Re, M., I
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2019, 142 : 300 - 306